# Mismatch Between Imaging and Histopathology Diagnosis in High and Low-Grade Gliomas: A Case Report

**Authors:** Pukar Adhikari, Jabir Ahamad Miya, Shishir Bhandari, Ganesh Adhikari, Ajit Shrestha, Nikesh Tiwari

PMC · DOI: 10.31729/jnma.v63i292.9261 · 2025-12-31

## TL;DR

A case report shows how brain tumor imaging can be misleading, highlighting the need for tissue diagnosis in glioma classification.

## Contribution

Highlights a rare case of radiologic-histopathologic discordance in oligodendroglioma diagnosis.

## Key findings

- Neuroimaging suggested a high-grade glioma, but histopathology revealed a WHO Grade 2 oligodendroglioma.
- The case emphasizes the importance of molecular profiling and tissue diagnosis for accurate glioma classification.

## Abstract

Oligodendrogliomas aie diffusely infiltrating gliomas classified as WHO grade 2 or 3 tumors. While typically presenting with chronic seizures, they may rarely demonstrate imaging features suggestive of high-grade malignancy. A 40-year-old lady with untreated seizures for one year presented with acute loss of consciousness and recurrent generalized tonic-clonic seizures. Neuroimaging (CT/MRI) revealed a left temporoparietal lesion with cystic changes and hemorrhage, suggesting high-grade glioma. Histopathological analysis following craniotomy unexpectedly demonstrated WHO Grade 2 oligodendroglioma. This case highlights significant radiologic-histopathologic discordance in glioma diagnosis, emphasizing that radiologic features of high-grade malignancy may occur in low-grade oligodendrogliomas. Tissue diagnosis with molecular profiling remains essential for accurate classification and management.

## Linked entities

- **Diseases:** oligodendroglioma (MONDO:0002540), glioma (MONDO:0021042)

## Full-text entities

- **Genes:** IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, ATRX (ATRX chromatin remodeler) [NCBI Gene 546] {aka JMS, MRX52, RAD54, RAD54L, XH2, XNP}, OLIG2 (oligodendrocyte transcription factor 2) [NCBI Gene 10215] {aka BHLHB1, OLIGO2, PRKCBP2, RACK17, bHLHe19}
- **Diseases:** brain tumors (MESH:D001932), urinary incontinence (MESH:D014549), necrosis (MESH:D009336), epilepsy (MESH:D004827), CNS tumors (MESH:D016543), OPD (MESH:C538089), Oligodendrogliomas (MESH:D009837), confusion (MESH:D003221), haemorrhage (MESH:D006470), mouth deviation (MESH:D009059), status epilepticus (MESH:D013226), seizure (MESH:D012640), fever (MESH:D005334), headaches (MESH:D006261), Gliomas (MESH:D005910), meningeal irritation (MESH:D008580), edema (MESH:D004487), loss of consciousness (MESH:D014474), 2 tumor (MESH:D009369)
- **Chemicals:** glucose (MESH:D005947), levetiracetam (MESH:D000077287), gadopentetate dimeglumine (MESH:D019786), Septillin (-)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12906742/full.md

---
Source: https://tomesphere.com/paper/PMC12906742